{
    "nctId": "NCT03332368",
    "briefTitle": "Clinical Study on Triple Negative Breast Cancer With Chinese Medicine",
    "officialTitle": "Clinical Study on Prevention and Treatment of Recurrent and Metastasis of Triple Negative Breast Cancer(TNBC) With Traditional Chinese Medicine(TCM)",
    "overallStatus": "UNKNOWN",
    "conditions": "Progression-Free-Survival, Recurrence, Overall Survival",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 620,
    "primaryOutcomeMeasure": "Progression-Free-Survival, PFS",
    "eligibilityCriteria": "Participants' inclusion criteria are as follows:\n\n1. The primary breast cancer after surgical treatment, the pathological diagnosis of breast epithelial tumors (breast cancer), ER, PR and Her-2 immunohistochemical results were negative;\n2. no recurrence of metastasis;\n3. card score \u2265 60 points;\n4. Female patients aged 18-75 years (including 18,75 years);\n5. there is no serious organic or functional disorders, no drugs and food allergy;\n6. willing to receive treatment, observation and inspection.\n\nParticipants' exclusion criteria are as follow:\n\n1. does not meet the inclusion criteria;\n2. patients expected to survive \\<6 months;\n3. combined with cardiovascular and cerebrovascular, liver, kidney, hematopoietic system of serious primary disease and mental illness;\n4. breastfeeding, pregnancy or women preparing for pregnancy;\n5. allergies and allergies to a variety of drugs;\n6. are participating in other drug subjects.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}